Rainbow Children's Medicare Ltd — Q4 FY26 earnings call
Summary generated by AI from the official transcript Rainbow Children's Medicare Ltd filed with BSE on 01 Jun 2026. Every statement cites a verbatim quote from that document — open any citation to read it. This is a record of what management said, not a recommendation. How we check these summaries
The short read
Rainbow Children's Medicare reported Q4 FY26 revenue of Rs 459.9 crore, up 24% year-on-year, with EBITDA of Rs 144.7 crore and PAT of Rs 78.2 crore. For the full year, revenue grew 12% to Rs 1,703 crore while EBITDA margin stood at 32%. Management discussed nearly 500 beds added during the year, ongoing expansion projects in Coimbatore, Gurugram, Pune, Bangalore and Indore, and outlined plans for around 900 beds currently under execution.
2 statements from this call are not shown because their supporting quotes could not be reproduced within our quoting limits. Nothing shown here is affected: every statement on this page carries its verified quote.
Numbers mentioned
Revenue: INR459.9 crores (Q4 FY26)
p. 4
“Coming to financials. For Q4 FY26, the company reported a revenue of INR459.9 crores, a growth of 24%, EBITDA of INR144.7 crores with a growth of 26% and a PAT of INR78.2 crores, a growth of 38% compared to the Q4 of the last financial year.”
Dr. Ramesh Kancharla, page 4 of the filed PDF · View the filing
Occupancy: 45.3% (Q4 FY26)
p. 4
“Occupancy for the quarter stood at 45.3%.”
Dr. Ramesh Kancharla, page 4 of the filed PDF · View the filing
Operating revenue: INR460 crores (Q4 FY26)
p. 5
“Our operating revenue for the quarter stood at INR460 crores, reflecting a growth of 24% compared to the corresponding quarter of the previous financial year.”
Vikas Maheshwari, page 5 of the filed PDF · View the filing
Revenue: INR1,703 crores (FY26)
p. 5
“For the full year FY26, our revenues stood at INR1,703 crores, reflecting a growth of 12% compared to FY25.”
Vikas Maheshwari, page 5 of the filed PDF · View the filing
EBITDA: INR544 crores (FY26)
p. 5
“For FY26, our EBITDA stood at INR544 crores, reflecting a growth of 11% compared to the previous financial year.”
Vikas Maheshwari, page 5 of the filed PDF · View the filing
EBITDA margin: 32% (FY26)
p. 5
“Our EBITDA margin for the current quarter stood at 31.5%, while for FY26, our EBITDA margin stood at 32%.”
Vikas Maheshwari, page 5 of the filed PDF · View the filing
PAT: INR282 crores (FY26)
p. 6
“For the FY26, our PAT stood at INR282 crores, registering a growth of 15.3% compared to FY25.”
Vikas Maheshwari, page 6 of the filed PDF · View the filing
Cash business share: 47.5% (Q4 FY26)
p. 6
“We had 47.5% cash business for the quarter, while the insurance business was at around 52%.”
Vikas Maheshwari, page 6 of the filed PDF · View the filing
Cash and liquidity: INR594 crores
p. 6
“I am pleased to inform that the company continued to maintain a strong balance sheet and healthy liquidity position of INR594 crores, which provides adequate flexibility to support our ongoing capital expenditure plans, growth initiatives and the potential inorganic opportunities.”
Vikas Maheshwari, page 6 of the filed PDF · View the filing
Capex: INR217 crores (FY26)
p. 6
“During the quarter, we invested INR61 crores on the ongoing capex plan. And for the full year, we have invested close to INR217 crores capex towards expanding and strengthening capabilities across existing and upcoming hospitals, in line with our long-term growth strategy.”
Vikas Maheshwari, page 6 of the filed PDF · View the filing
International patient revenue: INR 28.9 crores (FY26)
p. 13
“International patient revenue remained broadly flat during FY26 at approximately INR 28.9 crores.”
Vikas Maheshwari, page 13 of the filed PDF · View the filing
IVF revenue contribution: 3.7% of total revenue (FY26)
p. 13
“As for IVF, it contributed 3.7% of total revenue for the full year, with the contribution increasing quarter on quarter.”
Vikas Maheshwari, page 13 of the filed PDF · View the filing
ARPOB growth: about 8%
p. 18
“ARPOB has grown by about 8%, right?”
Dr. Ramesh Kancharla, page 18 of the filed PDF · View the filing
What management said it would do
A record of statements made on the call, in the words management used. Parakho does not forecast, endorse or assess them, and their presence here is not a view on whether they will happen.
Revenue growth — around 20% · FY27
stated as an aspiration by Abrarali Dalal
p. 5
“I'm looking forward to working closely with the leadership team to drive aspirational yet achievable growth of 20% in the current year while maintaining margins.”
Abrarali Dalal, page 5 of the filed PDF · View the filing
Coimbatore hospital commissioning — 130 beds · H2 FY28
stated firmly by Dr. Ramesh Kancharla
p. 4
“The regional hub hospital in Coimbatore of 130 beds is in an active construction phase now and we expect to commence operations in H2 FY28.”
Dr. Ramesh Kancharla, page 4 of the filed PDF · View the filing
Gurugram Sector 56 hospital commissioning — 125 beds · H2 FY28
stated firmly by Dr. Ramesh Kancharla
p. 4
“We continue to make significant good progress in our Gurugram projects, where we are trying to fast track the Sector 56 of 125 beds to commence operations in H2 FY28, and a large super specialty hub in Sector 44 of 325 beds is expected to commence operations in Q1 FY29.”
Dr. Ramesh Kancharla, page 4 of the filed PDF · View the filing
ARPP growth — 5%-6% annually
stated firmly by Dr. Ramesh Kancharla
p. 18
“As we have consistently indicated, we expect ARPP to grow by around 5%–6% annually.”
Dr. Ramesh Kancharla, page 18 of the filed PDF · View the filing
Mature hospital occupancy — around 60% · coming year
stated as an aspiration by Dr. Ramesh Kancharla
p. 19
“For the coming year, we believe mature hospitals should be able to operate at around 60% occupancy.”
Dr. Ramesh Kancharla, page 19 of the filed PDF · View the filing
Blended occupancy — 56%–57%
stated as an aspiration by Dr. Ramesh Kancharla
p. 19
“On a blended basis across the network, we would expect occupancy to be in the range of 56%–57%.”
Dr. Ramesh Kancharla, page 19 of the filed PDF · View the filing
Gurugram investment — INR 400 crores
stated firmly by Vikas Maheshwari
p. 15
“We have already incurred part of the expenditure and expect an additional investment of around INR 400 crores towards the Gurugram facilities.”
Vikas Maheshwari, page 15 of the filed PDF · View the filing
Maintenance capex — approximately INR 45 crores per year
stated firmly by Vikas Maheshwari
p. 15
“Maintenance capex is approximately INR 45 crores per year across our network of around 25 units.”
Vikas Maheshwari, page 15 of the filed PDF · View the filing
Q&A highlights
Management's answers to analyst questions, in Parakho's words rather than a transcript. Each row names who answered and carries the verbatim quote it was drawn from.
Management said the company remains debt-free and cash-rich, funding all expansion through internal accruals.
Answered by Vikas Maheshwari
Asked by Sucrit D. Patil: How is Rainbow optimizing its capital structure and managing debt given the capital-intensive expansion?
p. 7
“We currently have no debt on our books and hold close to INR ~700 (it is ~600 Cr, regret the error) crores in cash and cash equivalents.”
Vikas Maheshwari, page 7 of the filed PDF · View the filing
Management said they look for assets with at least 50 operational beds scalable to 100+ beds.
Answered by Dr. Ramesh Kancharla
Asked by Damayanti Kerai: What is Rainbow's M&A strategy and target hospital size?
p. 7
“Ideally, we would look at assets that have at least 50 operational beds with the ability to scale up to 100 beds or more.”
Dr. Ramesh Kancharla, page 7 of the filed PDF · View the filing
Management said roughly 9-10% came from acquired/new units, the rest was organic.
Answered by Vikas Maheshwari
Asked by Alankar Garude: How much of the Q4 IP discharge growth was organic versus from acquired units?
p. 9
“Alankar, around 9%–10% of the growth came from the acquired and newly added units, while the balance was organic.”
Vikas Maheshwari, page 9 of the filed PDF · View the filing
Management attributed it to the absence of seasonal volume uplift, with improvement seen in Q4.
Answered by Dr. Ramesh Kancharla
Asked by Rahul Jeewani: What drove the decline in occupancy at mature hospitals during the year?
p. 13
“In Q4, however, performance improved, and occupancy increased to approximately 52%.”
Dr. Ramesh Kancharla, page 13 of the filed PDF · View the filing
Management said geopolitical issues and deportations from Bangladesh and other countries hurt international patient flows.
Answered by Dr. Ramesh Kancharla
Asked by Rahul Jeewani: What was the impact of international patient disruptions?
p. 13
“Disruptions in these markets affected patient flows, and in some cases local coordinators were not available, resulting in a significant shortfall versus our expectations for international business.”
Dr. Ramesh Kancharla, page 13 of the filed PDF · View the filing
Management said a blended occupancy of 56-58% is the desirable range for the operating model.
Answered by Dr. Ramesh Kancharla
Asked by Vishal Manchanda: What occupancy level does management consider desirable at the group level?
p. 16
“When it comes to occupancy, our view is that a group-level occupancy of around 56%–58% is the desirable range for achieving our budgets and delivering the expected outcomes of our operating model.”
Dr. Ramesh Kancharla, page 16 of the filed PDF · View the filing
Management said ARPOB growth was mainly driven by case mix and increasing fertility contribution.
Answered by Dr. Ramesh Kancharla
Asked by Uttam Purohit: What were the ARPOB growth drivers this year?
p. 18
“In our case, ARPOB growth is predominantly driven by case mix. In addition, the increasing contribution from the fertility business has also supported ARPOB growth.”
Dr. Ramesh Kancharla, page 18 of the filed PDF · View the filing
Risks flagged
International patient volumes were affected by geopolitical developments and deportations from Bangladesh and other countries
p. 13
“Disruptions in these markets affected patient flows, and in some cases local coordinators were not available, resulting in a significant shortfall versus our expectations for international business.”
Dr. Ramesh Kancharla, page 13 of the filed PDF · View the filing
Middle East conflict escalation affected air connectivity and travel, impacting international patient inflows
p. 13
“Additionally, in Q4, the escalation of conflict in the Middle East affected air connectivity and travel, which also impacted international patient inflows.”
Saurabh Bhandari, page 13 of the filed PDF · View the filing
Absence of seasonal volume uplift affected occupancy at mature hospitals
p. 12
“The primary reason has been the absence of the seasonal volume uplift that typically benefits mature hospitals.”
Dr. Ramesh Kancharla, page 12 of the filed PDF · View the filing
Quality consistency gap experienced between hospitals in different cities
p. 14
“Thank you for bringing that to our attention. We take such feedback seriously and will continue working to ensure a more consistent experience across the entire Rainbow network.”
Dr. Ramesh Kancharla, page 14 of the filed PDF · View the filing
Generated by claude-sonnet-5. Source: the transcript as filed with BSE. We link to the exchange's copy; we do not host transcripts. Parakho is a data and screening tool, not an investment adviser — nothing here is a recommendation to buy, sell or hold.